Continuous intravascular glucose monitoring system for tight glycemic control (TGC) in the hospital
GlySure has raised €19M across 2 funding rounds from 2 investors, most recently a Series C round in Nov 2012. Based in UK; founded 2006; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2012-11-01 | Series C | €10M | Amadeus Capital Partners,Delta Partners | View deal → |
| 2012-01-01 | Series C | €8.4M | Amadeus Capital Partners,Delta Partners | View deal → |
